Nionyx Bio

New York, United States

Nionyx Bio builds AAV-based gene therapies to address some of the most potent kidney genetic diseases.

Sep 2025

Seed

Top Investors

2048 VenturesAIN VenturesNew York VenturesPathway BioventuresWhite Mug Healthcare

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Nionyx Bio's investors?

Nionyx Bio's investors include 2048 Ventures, AIN Ventures, New York Ventures, Pathway Bioventures, White Mug Healthcare.

Where is Nionyx Bio headquartered?

Nionyx Bio is headquartered in New York, United States.

What does Nionyx Bio do?

Nionyx Bio builds AAV-based gene therapies to address some of the most potent kidney genetic diseases.

What stage is Nionyx Bio at?

Nionyx Bio is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 29, 2025.

MLA

"Nionyx Bio — Funding & Investors." VCBacked, September 29, 2025, https://www.vcbacked.co/company/nionyx-bio. Accessed July 1, 2026.

APA

VCBacked. (2025). Nionyx Bio — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/nionyx-bio

Wikipedia (cite web)

{{cite web |title=Nionyx Bio — Funding & Investors |url=https://www.vcbacked.co/company/nionyx-bio |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 29, 2025.